Century Therapeutics, Inc. (IPSC)

Century Therapeutics Statistics

Total Valuation

IPSC has a market cap or net worth of $429.24 million. The enterprise value is $336.58 million.

Market Cap	429.24M
Enterprise Value	336.58M

Important Dates

The last earnings date was Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

IPSC has 180.35 million shares outstanding. The number of shares has increased by 34.10% in one year.

Current Share Class	180.35M
Shares Outstanding	180.35M
Shares Change (YoY)	+34.10%
Shares Change (QoQ)	+121.65%
Owned by Insiders (%)	3.18%
Owned by Institutions (%)	24.41%
Float	98.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.55
P/TBV Ratio	1.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.17.

Current Ratio	10.25
Quick Ratio	9.94
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.67% and return on invested capital (ROIC) is -23.45%.

Return on Equity (ROE)	-42.67%
Return on Assets (ROA)	-21.98%
Return on Invested Capital (ROIC)	-23.45%
Return on Capital Employed (ROCE)	-36.07%
Weighted Average Cost of Capital (WACC)	11.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-68,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +354.37% in the last 52 weeks. The beta is 1.56, so IPSC's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+354.37%
50-Day Moving Average	2.34
200-Day Moving Average	1.31
Relative Strength Index (RSI)	55.93
Average Volume (20 Days)	732,775

Short Selling Information

The latest short interest is 12.05 million, so 6.68% of the outstanding shares have been sold short.

Short Interest	12.05M
Short Previous Month	10.96M
Short % of Shares Out	6.68%
Short % of Float	12.27%
Short Ratio (days to cover)	10.72

Income Statement

Revenue	n/a
Gross Profit	-95.67M
Operating Income	-112.90M
Pretax Income	-107.85M
Net Income	-107.79M
EBITDA	-100.02M
EBIT	-112.90M
Earnings Per Share (EPS)	-$0.95

Balance Sheet

The company has $134.80 million in cash and $43.94 million in debt, with a net cash position of $90.86 million or $0.50 per share.

Cash & Cash Equivalents	134.80M
Total Debt	43.94M
Net Cash	90.86M
Net Cash Per Share	$0.50
Equity (Book Value)	264.74M
Book Value Per Share	1.47
Working Capital	125.47M

Cash Flow

In the last 12 months, operating cash flow was -$94.52 million and capital expenditures -$957,000, giving a free cash flow of -$95.47 million.

Operating Cash Flow	-94.52M
Capital Expenditures	-957,000
Depreciation & Amortization	12.88M
Net Borrowing	n/a
Free Cash Flow	-95.47M
FCF Per Share	-$0.53

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IPSC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.10%
Shareholder Yield	-34.10%
Earnings Yield	-25.22%
FCF Yield	-22.34%

Analyst Forecast

The average price target for IPSC is $4.25, which is 78.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.25
Price Target Difference	78.57%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	-10.90%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1